Impact of HIV infection and antiretroviral therapy in the older patient

Expert Review of Anti-Infective Therapy

Volumn 2, Issue 6, 2004, Pages 821-824

  Manfredi, Roberto ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CYTOKINE; INTERLEUKIN RECEPTOR; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; BLOOD TRANSFUSION; CLINICAL TRIAL; DISEASE COURSE; DISEASE SEVERITY; DRUG SAFETY; DRUG TOLERABILITY; EARLY DIAGNOSIS; EDITORIAL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; INTRAVENOUS DRUG ABUSE; LIFE EXPECTANCY; PATIENT CARE; PRACTICE GUIDELINE; SERODIAGNOSIS; SEXUAL TRANSMISSION; SURVIVAL TIME;

EID: 9944234450     PISSN: 14787210     EISSN: None     Source Type: Journal    
DOI: 10.1586/14789072.2.6.821     Document Type: Editorial

References (21)

1. Woolery WA. Occult HIV infection: diagnosis and treatment of older patients. Geriatrics 52, 51-61 (1997).
2. Bachus MA. HIV and the older adult. J. Gerentol. Nurs. 24, 41-46 (1998).
3. Keller MJ, Hausdorff JM, Kyne L et al. Is age a negative prognostic indicator in HIV infection or AIDS? Aging 11, 35-38 (1999).
4. Centers for Disease Control and Prevention. HIV/AIDS Surveil. Rep. 11, 16-25 (1999).
5. Zablotsky DL. Overlooked, ignored and forgotten: older women at risk for HIV infection and AIDS. Res. Aging 20, 760-766 (1998).
6. Yeni PG, Hammer SM, Hirsch MS et al. Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society - USA. J. Am. Med. Assoc. 292, 251-265 (2004).
7. Volberding PA. HIV therapy in 2003: consensus and controversy. AIDS 17(Suppl. 1), S4-S11 (2003).
8. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbid. Mortal. Wkly Rep. 41, 1-9 (2004).
9. Samet JH, Freedberg KA, Savetsky JB et al. Understanding delay to medical care for HIV infection: the long-term nonpresenter. AIDS 15, 77-85 (2001).
10. Manfredi R, Calza L, Chiodo F. Three to seven concurrent AIDS-defining disorders at first hospitalization of AIDS presenters as an unexpected emerging feature during the era of highly active antiretroviral therapy. AIDS 16, 2356-2358 (2002).
11. Manfredi R, Calza L, Cocchi D, Chiodo F. Antiretroviral treatment and advanced age: epidemiologic, laboratory and clinical features in the elderly. J. Acquir. Immune Defic. Syndr. 33, 112-114 (2003).
12. Tumbarello M, Rabagliati R, De Gaetano Donati K et al. Older HIV-positive patients in the era of highly active antiretroviral therapy: changing of a scenario. AIDS 17, 128-131 (2003).
13. Andrews L, Friedland G. Progress in HIV therapeutics and the challenge of adherence to antiretroviral therapy. Infect. Dis. Clin. North Am. 14, 901-928 (2000).
14. Manfredi R, Chiodo F. A case-control study of virological and immunological effects of highly active antiretroviral therapy in HIV-infected patients with advanced age. AIDS 14, 1475-1477 (2000 ).
15. Goetz MB, Boscardin WJ, Wiley D et al. Decreased recovery of CD4 lymphocytes in older HIV-infected patients beginning highly active antiretroviral therapy. AIDS 15, 1576-1579 (2001).
16. George AJT, Ritter MA. Thymic involution with ageing: obsolescence or good housekeeping? Immunol. Today 17, 267-272 (1996).
17. Douek DC, Koup RA. Evidence for thymic function in the elderly. Vaccine 18, 1638-1641 (2000).
18. Manfredi R, Calza L, Chiodo F. HIV disease among immigrants coming to Italy from outside of the European Union: a case-control study of epidemiological and clinical features. Epidemiol. Infect. 127, 527-533 (2001).
19. Calza L, Manfredi R, Chiodo F. Statins and fibrates for the treatment of hyperlipidemia in HIV-infected patients receiving HAART. AIDS 17, 851-859 (2003).
20. Dubé MP, Stein JH, Aberg JA et al. Guidelines for the evaluation and management of dyslipidemia in HIV-infected adults receiving antiretroviral therapy: recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group. Clin. Infect. Dis. 37, 613-627 (2003).
21. Manfredi R. Evolution of HIV disease in the third millennium: clinical and related economic issues. Int. J. Antimicrob. Agents 19, 251-253 (2002).